Sublingual Nodules: Diagnostic Markers of Metastatic Breast Cancer
- PMID: 29667148
- DOI: 10.1007/s11655-018-2837-1
Sublingual Nodules: Diagnostic Markers of Metastatic Breast Cancer
Abstract
Objective: To evaluate the diagnostic significance of sublingual nodules for metastasis of patients with breast cancer and further to explore the mechanisms of sublingual nodules.
Methods: The image data of 117 in-patients with breast cancer in stage I-IV in Tianjin Medical University Cancer Institute and Hospital from December 2009 to September 2011 were assessed retrospectively. All photos of patients' tongue were recorded by the digital camera of uniform type within 1 month after serological examination and regular re-examined by computed tomography (CT), magnetic resonance imaging and positron emission tomography CT. The presence of sublingual nodules was the positive standard. Chi square test and two-independent-sample test were used to determine the diagnostic value between the status of sublingual nodules and Clinico-pathological characteristics. The optimal cut-off of uric acid (UA) level to diagnose sublingual nodules was determined by receiver operating curve (ROC) analysis.
Results: Breast cancer patients with sublingual nodules had a higher risk of recurrence and/or metastasis than patients without it (P<0.001). Sublingual nodules was significantly correlated with increased serum UA level (P=0.001). The optimal cut-off value of UA level to diagnose sublingual nodules was 290 μmol/L. Furthermore, the elevated serum UA level (≥290 μmol/L) was significantly related to breast cancer recurrence and/or metastasis (P<0.001).
Conclusions: Sublingual nodules were potential diagnostic markers for metastatic breast cancer. The formation of sublingual nodules was associated with elevated level of serum UA.
Keywords: Chinese medicine; breast cancer; diagnosis; metastasis; recurrence; serum uric acid; sublingual nodule.
Similar articles
-
[Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].Zhonghua Fu Chan Ke Za Zhi. 2007 Jul;42(7):460-3. Zhonghua Fu Chan Ke Za Zhi. 2007. PMID: 17961335 Chinese.
-
The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.J BUON. 2016 Nov-Dec;21(6):1410-1418. J BUON. 2016. PMID: 28039701
-
The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.Clin Chim Acta. 2017 Jul;470:51-55. doi: 10.1016/j.cca.2017.04.023. Epub 2017 Apr 27. Clin Chim Acta. 2017. PMID: 28457854
-
LUCIS: lung cancer imaging studies.Dan Med J. 2012 Nov;59(11):B4542. Dan Med J. 2012. PMID: 23171752 Review.
-
Reexcision for positive margins in breast cancer: A predictive score of residual disease.Surg Oncol. 2015 Sep;24(3):129-35. doi: 10.1016/j.suronc.2015.08.003. Epub 2015 Aug 13. Surg Oncol. 2015. PMID: 26298198 Review.
Cited by
-
Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study.Sci Rep. 2024 Oct 30;14(1):26165. doi: 10.1038/s41598-024-77788-7. Sci Rep. 2024. PMID: 39478158 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical